Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study.
作者信息
Braun Leah T, Zopp Stephanie, Vogel Frederick, Honegger Jürgen, Rubinstein German, Schilbach Katharina, Künzel Heike, Beuschlein Felix, Reincke Martin
机构信息
Medizinische Klinik und Poliklinik IV, LMU Klinikum, München, Germany.
Department for Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
出版信息
Endocrine. 2021 Sep;73(3):762-766. doi: 10.1007/s12020-021-02719-9. Epub 2021 Apr 19.
Abstract
摘要
相似文献
1
Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study.
Endocrine. 2021 Sep;73(3):762-766. doi: 10.1007/s12020-021-02719-9. Epub 2021 Apr 19.
2
Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
J Neurosurg. 2018 Sep;129(3):629-641. doi: 10.3171/2017.3.JNS162245. Epub 2017 Oct 13.
3
[Metastasizing, predominantly basophilic adenoma of the anterior pituitary with recurrent Cushing disease after subtotal adrenalectomy].
Schweiz Z Pathol Bakteriol. 1955;18(6):1189-97.
4
Pituitary Apoplexy due to the Diagnostic Test in a Cushing"s Disease Patient.
Turk Neurosurg. 2018;28(2):323-325. doi: 10.5137/1019-5149.JTN.16730-15.1.
5
Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
Endocr J. 2010;57(9):833-7. doi: 10.1507/endocrj.k10e-140. Epub 2010 Jun 26.
6
Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Neurosurg Focus. 2020 Jun;48(6):E12. doi: 10.3171/2020.3.FOCUS2039.
7
Management of recurrent and refractory Cushing disease.
Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):560-8. doi: 10.1038/ncpendmet0947. Epub 2008 Aug 19.
8
Treatment options for Cushing disease after unsuccessful transsphenoidal surgery.
Neurosurg Focus. 2007;23(3):E8. doi: 10.3171/foc.2007.23.3.10.
9
Otolaryngic manifestations of Cushing disease.
Ear Nose Throat J. 2017 Aug;96(8):E28-E30. doi: 10.1177/014556131709600808.
10
Pituitary gland: Mortality in Cushing disease.
Nat Rev Endocrinol. 2016 Sep;12(9):502-3. doi: 10.1038/nrendo.2016.118. Epub 2016 Jul 22.
引用本文的文献
1
Cushing syndrome.
Nat Rev Dis Primers. 2025 Jan 23;11(1):4. doi: 10.1038/s41572-024-00588-w.
2
E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess.
Front Endocrinol (Lausanne). 2023 Nov 17;14:1249863. doi: 10.3389/fendo.2023.1249863. eCollection 2023.
3
Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited.
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3723-e3730. doi: 10.1210/clinem/dgac379.
本文引用的文献
1
Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.
Endocrine. 2020 Nov;70(2):218-231. doi: 10.1007/s12020-020-02432-z. Epub 2020 Aug 2.
2
Pasireotide treatment significantly reduces tumor volume in patients with Cushing's disease: results from a Phase 3 study.
Pituitary. 2020 Jun;23(3):203-211. doi: 10.1007/s11102-019-01021-2.
3
Toward a Diagnostic Score in Cushing's Syndrome.
Front Endocrinol (Lausanne). 2019 Nov 8;10:766. doi: 10.3389/fendo.2019.00766. eCollection 2019.
4
Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge.
Front Endocrinol (Lausanne). 2019 Nov 8;10:740. doi: 10.3389/fendo.2019.00740. eCollection 2019.
5
Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review.
J Endocr Soc. 2019 Mar 25;3(5):996-1008. doi: 10.1210/js.2019-00090. eCollection 2019 May 1.
6
Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome.
J Steroid Biochem Mol Biol. 2019 Jun;190:193-197. doi: 10.1016/j.jsbmb.2019.04.004. Epub 2019 Apr 5.
7
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12.
8
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.
Pituitary. 2017 Aug;20(4):422-429. doi: 10.1007/s11102-017-0801-2.
9
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: DIAGNOSIS OF RECURRENCE IN CUSHING DISEASE.
Endocr Pract. 2016 Dec;22(12):1436-1448. doi: 10.4158/EP161512.DSCR. Epub 2016 Sep 19.
10
POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
Endocr Pract. 2016 Oct;22(10):1216-1223. doi: 10.4158/EP161380.OR. Epub 2016 Jul 13.
Zotero 插件